In October 2014, a large inflatable tomato greeted officials at the Enlarged Board of Appeal of the European Patent Office (EPO). Surrounding the officials were protestors waving placards that said “free broccoli” and “free tomato”. The demonstration was organised by No Patents on Seeds, a coalition of non-governmental and farmers’ organisations concerned about patents covering seeds, plants and farm animals. In addition, an online petition set up by campaigning group Avaaz to stop the further patenting of fruit and vegetables in Europe has so far generated more than two million signatures.
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk
11 November 2026 The parties granted each other the right to use their respective patented inventions in the field of infectious disease but are not obligated to make any payments in connection with the licences.
28 October 2026 Both companies have agreed to dismiss claims and counterclaims involving Amgen’s 2 mg aflibercept biosimilar, while their wider feud continues.
23 October 2026 Following the Federal Circuit’s decision to uphold the invalidation of three patents, the parties are set to drop their remaining claims, despite 10x’s separate multi-million dollar jury win.